HCA (HCA) Upgraded at J P Morgan Chase & Co

J P Morgan Chase & Co upgraded shares of HCA (NYSE:HCA) from a neutral rating to an overweight rating in a report released on Thursday, Marketbeat Ratings reports.

A number of other research analysts have also recently commented on HCA. Argus decreased their price objective on HCA from $100.00 to $93.00 and set a buy rating on the stock in a report on Monday, August 14th. Zacks Investment Research upgraded HCA from a sell rating to a hold rating in a research note on Tuesday, August 8th. BidaskClub cut HCA from a sell rating to a strong sell rating in a research note on Saturday, August 5th. Robert W. Baird restated a buy rating on shares of HCA in a research note on Thursday, September 28th. Finally, ValuEngine upgraded HCA from a hold rating to a buy rating in a research note on Monday, October 2nd. Two equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and eighteen have given a buy rating to the company. The company currently has an average rating of Buy and a consensus target price of $90.20.

HCA (HCA) traded down $0.95 on Thursday, reaching $84.05. The company had a trading volume of 3,490,000 shares, compared to its average volume of 2,295,764. HCA has a 12-month low of $70.00 and a 12-month high of $91.03. The firm has a market capitalization of $29,758.16, a PE ratio of 12.75, a PEG ratio of 1.23 and a beta of 0.55. The company has a quick ratio of 1.41, a current ratio of 1.68 and a debt-to-equity ratio of -6.46.

HCA (NYSE:HCA) last released its quarterly earnings data on Tuesday, October 31st. The company reported $1.21 EPS for the quarter, meeting analysts’ consensus estimates of $1.21. HCA had a negative return on equity of 47.16% and a net margin of 6.13%. The firm had revenue of $10.70 billion for the quarter, compared to analysts’ expectations of $10.70 billion. During the same period in the prior year, the firm posted $1.45 earnings per share. The firm’s quarterly revenue was up 4.1% on a year-over-year basis. equities analysts predict that HCA will post 6.56 earnings per share for the current year.

In other news, insider Michael S. Cuffe sold 2,150 shares of the company’s stock in a transaction on Tuesday, October 17th. The stock was sold at an average price of $78.00, for a total transaction of $167,700.00. Following the sale, the insider now owns 12,476 shares of the company’s stock, valued at $973,128. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Victor L. Campbell sold 8,000 shares of the company’s stock in a transaction on Wednesday, November 8th. The stock was sold at an average price of $78.00, for a total value of $624,000.00. Following the sale, the senior vice president now directly owns 127,275 shares in the company, valued at approximately $9,927,450. The disclosure for this sale can be found here. Insiders have sold 22,450 shares of company stock worth $1,737,681 in the last ninety days. Corporate insiders own 2.90% of the company’s stock.

Several institutional investors have recently bought and sold shares of HCA. US Bancorp DE increased its position in shares of HCA by 10.9% during the second quarter. US Bancorp DE now owns 22,999 shares of the company’s stock worth $2,006,000 after acquiring an additional 2,260 shares during the period. Acadian Asset Management LLC increased its position in shares of HCA by 366.5% during the second quarter. Acadian Asset Management LLC now owns 32,787 shares of the company’s stock worth $2,859,000 after acquiring an additional 25,758 shares during the period. Janney Montgomery Scott LLC increased its position in shares of HCA by 0.4% during the second quarter. Janney Montgomery Scott LLC now owns 3,174 shares of the company’s stock worth $277,000 after acquiring an additional 14 shares during the period. Rothschild Asset Management Inc. purchased a new stake in shares of HCA during the second quarter worth $448,000. Finally, Lee Financial Co purchased a new stake in shares of HCA during the second quarter worth $125,000. 75.35% of the stock is currently owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY WARNING: This story was first reported by Community Financial News and is the property of of Community Financial News. If you are viewing this story on another publication, it was illegally stolen and reposted in violation of US & international copyright legislation. The correct version of this story can be read at https://www.com-unik.info/2017/12/03/hca-hca-upgraded-at-j-p-morgan-chase-co.html.

HCA Company Profile

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Analyst Recommendations for HCA (NYSE:HCA)

What are top analysts saying about HCA Holdings Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for HCA Holdings Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit